Chloroprocaine for Inguinal Herniorrhaphy

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 16, 2015

Primary Completion Date

September 7, 2017

Study Completion Date

December 4, 2018

Conditions
Spinal Anesthesia
Interventions
DRUG

Chloroprocaine 1% Injectable Solution

"standard CSE procedure in outpatients for inguinal hernia. The first spinal dose of chloroprocaine 1% to start with is 50mg. This dose has been successfully used for spinal anesthesia in hernia repair outpatients to reach an adequate analgesia. 2,5 microgram of sufentanil will be added for prolongation of the analgesia. The testing interval is 2 mg.~Efficacy of the analgesia will be evaluated:~Successful : sensory block at or above T6 dermatome bilateral at the beginning of surgery without additional analgesia during surgery. Unsuccessful: sensory block under T6 dermatome bilateral and/or VAPS is more than 10 mm at the beginning of surgery what necessitates additional epidurals analgesia.~Patients who indicate an ineffective result will receive a rescue treatment by the administration of 5 ml chloroprocaine 3% epidural every 5 minutes with maximum of 30ml. When CSE fails, general anesthesia will be performed."

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT03805503 - Chloroprocaine for Inguinal Herniorrhaphy | Biotech Hunter | Biotech Hunter